Inspire Medical Systems 8-K: Officer/Director Changes, Comp Arrangements
Ticker: INSP · Form: 8-K · Filed: Feb 5, 2024 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Feb 5, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**Inspire Medical Systems reported executive changes and compensation updates, keep an eye on leadership stability.**
AI Summary
Inspire Medical Systems, Inc. filed an 8-K on February 5, 2024, reporting events that occurred on January 30, 2024. This filing primarily concerns the departure or election of directors and officers, as well as compensatory arrangements for certain officers. While specific names and dollar amounts are not detailed in this summary filing, it signals potential changes in leadership or executive compensation structures. This matters to investors as changes in executive leadership or compensation can impact a company's strategic direction, operational efficiency, and financial performance, potentially affecting stock value.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, directly influencing investor confidence and stock performance.
Risk Assessment
Risk Level: medium — The filing indicates changes in leadership and compensation, which can introduce uncertainty regarding future company direction and stability, warranting a medium risk assessment.
Analyst Insight
A smart investor would monitor subsequent filings or company announcements for specific details on the executive changes and compensation structures, as these details will provide a clearer picture of potential impacts on the company's future performance and stock value.
Key Numbers
- 001-38468 — Commission File Number (Identifies the company's registration with the SEC.)
- 20240130 — Conformed Period of Report (Indicates the date of the events being reported in the 8-K.)
- 20240205 — Filed As Of Date (The date the 8-K was officially filed with the SEC.)
- 16 — Public Document Count (Number of documents included in the filing.)
- $0.001 — par value per share (The nominal value of each common stock share.)
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — registrant
- January 30, 2024 (date) — date of earliest event reported
- February 5, 2024 (date) — filing date
- 001-38468 (other) — Commission File Number
- 26-1377674 (other) — I.R.S. Employer Identification No.
- INSP (other) — Trading Symbol
- New York Stock Exchange (other) — exchange where registered
Forward-Looking Statements
- Inspire Medical Systems will provide more detailed information regarding the specific officer and director changes and compensation arrangements in future filings or press releases. (Inspire Medical Systems, Inc.) — high confidence, target: Q1 2024
- The market will react to the specifics of the leadership changes once they are fully disclosed, potentially causing short-term stock volatility. (INSP stock) — medium confidence, target: Q1 2024
FAQ
What specific items are being reported in this 8-K filing by Inspire Medical Systems, Inc.?
This 8-K filing reports on 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' under Item 5.02, and 'Financial Statements and Exhibits' under Item 9.01, as per the 'ITEM INFORMATION' section.
When did the earliest event reported in this 8-K filing occur?
The earliest event reported in this 8-K filing occurred on January 30, 2024, as stated in the 'Date of report (Date of earliest event reported): January 30, 2024' section.
What is the trading symbol and the exchange where Inspire Medical Systems, Inc. common stock is registered?
Inspire Medical Systems, Inc.'s Common Stock, $0.001 par value per share, trades under the symbol INSP and is registered on the New York Stock Exchange, as detailed under 'Securities registered pursuant to Section 12(b) of the Act'.
What is the business address and phone number of Inspire Medical Systems, Inc.?
The business address for Inspire Medical Systems, Inc. is 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416, and their business phone number is (844) 672-4357, according to the 'BUSINESS ADDRESS' and 'Registrant’s telephone number' sections.
What is the Central Index Key (CIK) for Inspire Medical Systems, Inc.?
The Central Index Key (CIK) for Inspire Medical Systems, Inc. is 0001609550, as listed under 'COMPANY DATA' in the filing header.
Filing Stats: 649 words · 3 min read · ~2 pages · Grade level 10 · Accepted 2024-02-05 16:03:10
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
Filing Documents
- insp-20240130.htm (8-K) — 27KB
- mcnpr2024-02x05.htm (EX-99.1) — 8KB
- image.jpg (GRAPHIC) — 39KB
- 0001609550-24-000011.txt ( ) — 219KB
- insp-20240130.xsd (EX-101.SCH) — 2KB
- insp-20240130_lab.xml (EX-101.LAB) — 24KB
- insp-20240130_pre.xml (EX-101.PRE) — 13KB
- insp-20240130_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated February 5 , 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: February 5, 2024 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel 3